Late valacyclovir for herpes yields greater response
Posted on | June 11, 2007 |
This is great news. Not so new to me, but a bit of hope for anyone who may be newly diagnosed.
Therapy with valacyclovir (Valtrex, GlaxoSmithKline), started within three months of infection with either herpes simplex virus type 1 (HSV-1) or HSV type 2 (HSV-2), reduces the rate of symptomatic outbreaks compared with placebo, Seattle investigators report in the Journal of Sexually Transmitted Diseases.
I can’t recommend an antiviral enough. But for over the counter treatments, I’m a fan of Dynamiclear and H-Balm all the way!
Tags: herpes, valtrex, dynamiclear, hbalm, herpes treatment, suppressive therapy